There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen Inc (NASDAQ:BIIB) and Viveve Medical Inc (NASDAQ:VIVE) with bullish sentiments.
Biogen Inc (BIIB)
In a report issued on July 6, Phil Nadeau from Cowen & Co. maintained a Buy rating on Biogen Inc, with a price target of $408. The company’s shares opened today at $347.54.
According to TipRanks.com, Nadeau is a 5-star analyst with an average return of 16.1% and a 57.9% success rate. Nadeau covers the Healthcare sector, focusing on stocks such as Rocket Pharmaceuticals Inc, Rhythm Pharmaceuticals Inc, and Voyager Therapeutics Inc.
Biogen Inc has an analyst consensus of Strong Buy, with a price target consensus of $366.79, implying a 5.5% upside from current levels. In a report issued on June 28, Mizuho Securities also maintained a Buy rating on the stock with a $423 price target.
.
See today’s analyst top recommended stocks >>
Viveve Medical Inc (VIVE)
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Viveve Medical Inc, with a price target of $4. The company’s shares opened today at $3.01.
Yang wrote:
“We project total company sales of $134.6 mil in 2028 and we estimate 2028 FCF of $51.2 mil. We assume a terminal value of 3.5x estimated 2028 FCF and we use a 10.0% discount rate to derive a $4 per share price target. In addition, we also apply a peer group analysis and precedent transaction analysis to value VIVE. We apply a 3x EV/Sales multiple to our estimated 2022 sales figure of $69.0 mil discounted back using a 10% discount rate, to derive a $4 PT.”
According to TipRanks.com, Yang is a 5-star analyst with an average return of 22.9% and a 54.9% success rate. Yang covers the Healthcare sector, focusing on stocks such as Nightstar Therapeutics Limited, Alder Biopharmaceuticals, and Audentes Therapeutics.
Currently, the analyst consensus on Viveve Medical Inc is a Strong Buy with an average price target of $7.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
